1489 related articles for article (PubMed ID: 28464797)
21. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
[TBL] [Abstract][Full Text] [Related]
22. Comparing laboratory costs of smear/culture and Xpert
Naidoo P; Dunbar R; du Toit E; van Niekerk M; Squire SB; Beyers N; Madan J
Int J Tuberc Lung Dis; 2016 Oct; 20(10):1377-1385. PubMed ID: 27725051
[TBL] [Abstract][Full Text] [Related]
23. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility.
Geleta DA; Megerssa YC; Gudeta AN; Akalu GT; Debele MT; Tulu KD
BMC Microbiol; 2015 Oct; 15():220. PubMed ID: 26483194
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of TB diagnostic technologies in Ethiopia: a modelling study.
Assebe LF; Erena AK; Fikadu L; Alemu B; Baruda YS; Jiao B
Cost Eff Resour Alloc; 2024 May; 22(1):43. PubMed ID: 38773636
[TBL] [Abstract][Full Text] [Related]
27. Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.
Kaso AW; Hailu A
PLoS One; 2021; 16(10):e0259056. PubMed ID: 34695153
[TBL] [Abstract][Full Text] [Related]
28. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF.
Ullah I; Javaid A; Masud H; Ali M; Basit A; Ahmad W; Younis F; Yasmin R; Khan A; Jabbar A; Husain M; Butt ZA
J Med Microbiol; 2017 Apr; 66(4):412-418. PubMed ID: 28425873
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States.
Choi HW; Miele K; Dowdy D; Shah M
Int J Tuberc Lung Dis; 2013 Oct; 17(10):1328-35. PubMed ID: 24025386
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance of smear microscopy and incremental yield of Xpert in detection of pulmonary tuberculosis in Rwanda.
Ngabonziza JC; Ssengooba W; Mutua F; Torrea G; Dushime A; Gasana M; Andre E; Uwamungu S; Nyaruhirira AU; Mwaengo D; Muvunyi CM
BMC Infect Dis; 2016 Nov; 16(1):660. PubMed ID: 27825314
[TBL] [Abstract][Full Text] [Related]
31. Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
Kendall EA; Schumacher SG; Denkinger CM; Dowdy DW
PLoS Med; 2017 Dec; 14(12):e1002472. PubMed ID: 29240766
[TBL] [Abstract][Full Text] [Related]
32. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
Rice JP; Seifert M; Moser KS; Rodwell TC
PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
[TBL] [Abstract][Full Text] [Related]
33. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN
PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877
[TBL] [Abstract][Full Text] [Related]
34. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation.
Reither K; Manyama C; Clowes P; Rachow A; Mapamba D; Steiner A; Ross A; Mfinanga E; Sasamalo M; Nsubuga M; Aloi F; Cirillo D; Jugheli L; Lwilla F
J Infect; 2015 Apr; 70(4):392-9. PubMed ID: 25312863
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
O'Grady J; Bates M; Chilukutu L; Mzyece J; Cheelo B; Chilufya M; Mukonda L; Mumba M; Tembo J; Chomba M; Kapata N; Maeurer M; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
Clin Infect Dis; 2012 Nov; 55(9):1171-8. PubMed ID: 22806590
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
Muttamba W; Ssengooba W; Sekibira R; Kirenga B; Katamba A; Joloba M
PLoS One; 2018; 13(3):e0194741. PubMed ID: 29566056
[TBL] [Abstract][Full Text] [Related]
37. Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert(®) MTB/RIF.
Adelman MW; Tsegaye M; Kempker RR; Alebachew T; Haile K; Tesfaye A; Aseffa A; Blumberg HM
Int J Tuberc Lung Dis; 2015 Oct; 19(10):1197-203. PubMed ID: 26459533
[TBL] [Abstract][Full Text] [Related]
38. Improving rifampicin-resistant tuberculosis diagnosis using Xpert
Dunbar R; Naidoo P; Beyers N; Langley I
Int J Tuberc Lung Dis; 2018 Aug; 22(8):890-898. PubMed ID: 29991398
[TBL] [Abstract][Full Text] [Related]
39. Multidrug Resistant Mycobacterium tuberculosis Among Military and Civilian Personnel seen at a Tertiary Military Hospital, Manila, Philippines (2015-2018).
Velasco JM; Gaurano N; Valderama MT; Nogrado K; Diones PC; Lopez MN; Liao C; Chua D; Develos M; Fernandez S; Macareo L; Swierczewski B
Mil Med; 2020 Aug; 185(7-8):e1106-e1111. PubMed ID: 31915831
[TBL] [Abstract][Full Text] [Related]
40. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
